Exact Sciences to Participate in November Investor Conference
Exact Sciences (Nasdaq: EXAS), a leader in cancer screening and diagnostic tests, has announced its upcoming participation in the Jefferies London Healthcare Conference. The company will host a fireside chat on Tuesday, November 19, 2024 at 6:00 a.m. ET in London. Investors can access the webcast through the investor relations section of Exact Sciences' website.
Exact Sciences (Nasdaq: EXAS), un leader nei test di screening e diagnostica per il cancro, ha annunciato la sua prossima partecipazione al Jefferies London Healthcare Conference. L'azienda ospiterà una chiacchierata informale il martedì 19 novembre 2024 alle 6:00 a.m. ET a Londra. Gli investitori possono accedere al webcast attraverso la sezione relazioni con gli investitori del sito web di Exact Sciences.
Exact Sciences (Nasdaq: EXAS), un líder en pruebas de detección y diagnóstico del cáncer, ha anunciado su próxima participación en la Jefferies London Healthcare Conference. La empresa llevará a cabo una charla informal el martes 19 de noviembre de 2024 a las 6:00 a.m. ET en Londres. Los inversores pueden acceder al webcast a través de la sección de relaciones con inversores del sitio web de Exact Sciences.
엑잭트 사이언스 (Nasdaq: EXAS)는 암 조기 발견 및 진단 검사 분야의 선두주자로, 제퍼리스 런던 헬스케어 콘퍼런스에 참여할 예정이라고 발표했습니다. 이 회사는 2024년 11월 19일 화요일 오전 6시(ET) 런던에서 파이어사이드 채팅을 진행합니다. 투자자들은 엑잭트 사이언스 웹사이트의 투자자 관계 섹션을 통해 웹캐스트에 접근할 수 있습니다.
Exact Sciences (Nasdaq: EXAS), un leader dans le dépistage et les tests diagnostiques du cancer, a annoncé sa prochaine participation à la Jefferies London Healthcare Conference. L'entreprise organisera une discussion informelle le mardi 19 novembre 2024 à 6h00, heure de l'Est, à Londres. Les investisseurs peuvent accéder à la diffusion en direct via la section des relations investisseurs du site Web d'Exact Sciences.
Exact Sciences (Nasdaq: EXAS), ein führendes Unternehmen im Bereich der Krebsfrüherkennung und Diagnosetests, hat seine bevorstehende Teilnahme an der Jefferies London Healthcare Conference angekündigt. Das Unternehmen wird am Dienstag, den 19. November 2024 um 6:00 Uhr ET in London eine Gesprächsrunde gestalten. Investoren können über den Bereich Investor Relations der Website von Exact Sciences auf das Webcast zugreifen.
- None.
- None.
-
Jefferies London Healthcare Conference,
London
Fireside chat on Tuesday, November 19, 2024 at 6:00 a.m. ET
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241101637242/en/
Erik Holznecht
Exact Sciences Corp.
investorrelations@exactsciences.com
608-800-6605
Source: Exact Sciences Corp.
FAQ
When is Exact Sciences (EXAS) presenting at the Jefferies London Healthcare Conference?
How can investors watch Exact Sciences' (EXAS) Jefferies Conference presentation?
What type of event will Exact Sciences (EXAS) participate in at the Jefferies Conference?
Where is the Jefferies Healthcare Conference featuring Exact Sciences (EXAS) being held?
